In this population-based study, we aimed to investigate the effect of skincare product use on the risk of pre- and postmenopausal breast cancer, estrogen receptor positive (ER+) and negative (ER-) breast cancer and cancer of the endometrium. The gene discussed is ESR1; the disease is breast cancer.